KHCM
ALBO

Kettle Hill Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Kettle Hill Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25,268
Closed -$414K – 65
2020
Q1 		$414K Buy
+25,268
New +$556K 0.14% 48

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kettle Hill Capital Management's ALBO Position: Q2 2020 in Review

Kettle Hill Capital Management sold out of Albireo Pharma Inc (ALBO) in Q2 2020, closing a stake of 25,268 shares — an estimated $414K sold.

Kettle Hill Capital Management first reported a position in ALBO in Q1 2020 and held it in 1 quarter. The position peaked at $414K in Q1 2020. 82 funds tracked by Wall St. Rank hold ALBO as of Q2 2020.

  • Kettle Hill Capital Management reported no remaining Albireo Pharma Inc position as of Q2 2020 after selling out during the quarter.
  • Kettle Hill Capital Management sold 25,268 Albireo Pharma Inc shares in Q2 2020, an estimated $414K.
  • Kettle Hill Capital Management first reported a position in Albireo Pharma Inc in Q1 2020 and held it in 1 quarter.
  • Kettle Hill Capital Management's Albireo Pharma Inc position peaked at $414K in Q1 2020.
  • 82 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2020.

Based on Kettle Hill Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.